Fukushima Nana, Miyamoto Yuki, Yamauchi Junji
Laboratory of Molecular Neuroscience and Neurology, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
Laboratory of Molecular Pharmacology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
Pathophysiology. 2024 Aug 26;31(3):420-435. doi: 10.3390/pathophysiology31030032.
Small GTP-binding proteins of the Rab family regulate intracellular vesicle trafficking across many aspects of the transport system. Among these, Rab9 is recognized for its role in controlling the transport system not only around the trans-Golgi network but also around the late endosome. However, the specific functions across different cell types and tissues remain unclear. Here, for the first time, we report that Rab9 negatively regulates morphological changes in the FBD-102b cell line, an oligodendroglial precursor cell line undergoing morphological differentiation. The knockdown of Rab9 led to an increase in cell shape alterations characterized by widespread membrane extensions. These changes were accompanied by increased expression levels of oligodendroglial cell differentiation and myelination marker proteins. Notably, the knockdown of Rab9 was capable of recovering defective cell morphological changes induced by tunicamycin, an inducer of endoplasmic reticulum (ER) stress, which is one of the major causes of oligodendroglial cell diseases such as Pelizaeus-Merzbacher disease (PMD, currently known as hypomyelinating leukodystrophy type 1 [HLD1]). In addition, Rab9 knockdown recovered levels of ER stress marker proteins and differentiation markers. Similar results were obtained in the cases of dithiothreitol (DTT), another chemical ER stress inducer, as well as HLD1-associated proteolipid protein 1 (PLP1) mutant protein. These results indicate a unique role for Rab9 in oligodendroglial cell morphological changes, suggesting its potential as a therapeutic target for mitigating diseases such as HLD1 at the molecular and cellular levels.
Rab家族的小GTP结合蛋白在运输系统的多个方面调节细胞内囊泡运输。其中,Rab9不仅在反式高尔基体网络周围,而且在晚期内体周围的运输系统控制中发挥作用,因而受到认可。然而,Rab9在不同细胞类型和组织中的具体功能仍不清楚。在此,我们首次报告Rab9负向调节FBD - 102b细胞系(一种正在经历形态分化的少突胶质前体细胞系)的形态变化。Rab9基因敲低导致以广泛的膜延伸为特征的细胞形状改变增加。这些变化伴随着少突胶质细胞分化和髓鞘形成标记蛋白表达水平的增加。值得注意的是,Rab9基因敲低能够恢复由衣霉素(一种内质网(ER)应激诱导剂)诱导的有缺陷的细胞形态变化,衣霉素是诸如佩利措伊斯 - 默茨巴赫病(PMD,目前称为1型低髓鞘性脑白质营养不良[HLD1])等少突胶质细胞疾病的主要病因之一。此外,Rab9基因敲低恢复了内质网应激标记蛋白和分化标记的水平。在另一种化学内质网应激诱导剂二硫苏糖醇(DTT)以及与HLD1相关的蛋白脂蛋白1(PLP1)突变蛋白的情况下也获得了类似结果。这些结果表明Rab9在少突胶质细胞形态变化中具有独特作用,提示其在分子和细胞水平上作为减轻诸如HLD1等疾病的治疗靶点的潜力。